Quarterly Revenue
$93.76 M
+$85.57 M+1044.54%
30 September 2024
Summary:
Day One Biopharmaceuticals quarterly revenue is currently $93.76 million, with the most recent change of +$85.57 million (+1044.54%) on 30 September 2024. DAWN quarterly revenue is now -84.16% below its all-time high of $591.83 million, reached on 31 March 2021.DAWN Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$101.95 M
+$93.76 M+1144.54%
30 September 2024
Summary:
Day One Biopharmaceuticals TTM revenue is currently $101.95 million, with the most recent change of +$93.76 million (+1144.54%) on 30 September 2024. DAWN TTM revenue is now -94.59% below its all-time high of $1.89 billion, reached on 31 March 2021.DAWN TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DAWN Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | -80.3% | -94.1% |
DAWN Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +1044.5% | at high | +1144.5% | ||
| 5 y | 5 years | -84.2% | +1044.5% | -94.6% | +1144.5% | ||
| alltime | all time | -84.2% | +1044.5% | -94.6% | +1144.5% |
Day One Biopharmaceuticals Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $93.76 M(+1044.5%) | $101.95 M(+1144.5%) |
| June 2024 | - | $8.19 M(-98.6%) | $8.19 M(-99.6%) |
| Mar 2021 | - | $591.83 M(+24.1%) | $1.89 B(+4.6%) |
| Dec 2020 | - | $476.88 M(+3.8%) | $1.80 B(+6.6%) |
| Sept 2020 | - | $459.62 M(+28.6%) | $1.69 B(-1.0%) |
| June 2020 | - | $357.41 M(-29.8%) | $1.71 B(+0.4%) |
| Mar 2020 | - | $509.46 M(+39.2%) | $1.70 B(-1.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | - | $365.93 M(-23.3%) | $1.73 B(+0.0%) |
| Sept 2019 | - | $477.19 M(+36.0%) | $1.73 B(+4.8%) |
| June 2019 | - | $350.75 M(-34.1%) | $1.65 B(+2.1%) |
| Mar 2019 | - | $531.88 M(+45.6%) | $1.61 B(+49.2%) |
| Dec 2018 | - | $365.24 M(-8.4%) | $1.08 B(+51.0%) |
| Sept 2018 | - | $398.94 M(+25.8%) | $716.02 M(+125.8%) |
| June 2018 | - | $317.07 M | $317.07 M |
FAQ
- What is Day One Biopharmaceuticals quarterly revenue?
- What is the all time high quarterly revenue for Day One Biopharmaceuticals?
- What is Day One Biopharmaceuticals TTM revenue?
- What is the all time high TTM revenue for Day One Biopharmaceuticals?
What is Day One Biopharmaceuticals quarterly revenue?
The current quarterly revenue of DAWN is $93.76 M
What is the all time high quarterly revenue for Day One Biopharmaceuticals?
Day One Biopharmaceuticals all-time high quarterly revenue is $591.83 M
What is Day One Biopharmaceuticals TTM revenue?
The current TTM revenue of DAWN is $101.95 M
What is the all time high TTM revenue for Day One Biopharmaceuticals?
Day One Biopharmaceuticals all-time high TTM revenue is $1.89 B